News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Extendicare Inc. Announces Election Of Malen Ng To Board Of Directors
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MARKHAM, ONTARIO--(CCNMatthews - May 5, 2005) - Extendicare Inc. (TSX:EXE.MV)(TSX:EXE.SV)(NYSE:EXE) announced today the election of Malen Ng to its Board of Directors, effective May 5, 2005 for a three-year term.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Layoffs
TScan cuts 75% of workforce while shifting focus to solid tumor program
September 3, 2026
·
2 min read
·
Angela Gabriel
Funding
US to grant up to $125M for personalized RNA manufacturing innovation
September 3, 2026
·
2 min read
·
Michael Gibney
Deals
GSK inks another Asia alliance, betting up to $1.3B for HUTCHMED’s cancer therapy
September 3, 2026
·
1 min read
·
Tristan Manalac
FDA
Novartis’ and BMS’ paused CAR T trials, RevMed’s pancreatic cancer approval, more MFN deals
September 2, 2026
·
2 min read
·
Jef Akst